Verrica Pharmaceuticals Inc.

EDGAR

Market value

$64.16M

17,178,786 shares as of 2026-11-05, at $3.735 a share (VRCA, IEX close on 2026-11-12) Primary-source evidence

Annual consolidated revenue for 2025: about USD 35.58M, using the latest filing vintage with reviewed corrections applied. Corrected values apply reviewed corrections and remain separate from issuer reports. The previous period, 2024, was about USD 7.566M.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

Window: transactions dated on or after 2025-11-22.

Open-market purchases (code P)
12 transactions, 4,278,576 shares
Sum of shares × price per share: 18,183,587.505
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

  • 2026-08-18 Kirby John J. P 5,000 4.93
  • 2026-08-18 Rosenberg Noah L. P 2,030 4.92
  • 2026-08-17 Zawitz David P 6,000 4.98
  • 2026-08-17 Rosenberg Noah L. P 4,200 4.91
  • 2026-08-17 Rieger Jayson P 5,000 4.91

5% holders (Schedule 13D and 13G)

  • Dellora Investments LP 5.2% SCHEDULE 13G 09/30/2026
  • Kevin Pyun 5.2% SCHEDULE 13G 09/30/2026
  • Affinity Asset Advisors, LLC 4.99% SCHEDULE 13G/A 09/30/2026

Institutional holders (Form 13F)

  • Caligan Partners LP 923,910 SH
  • CANNELL CAPITAL LLC 693,552 SH
  • Affinity Asset Advisors, LLC 688,654 SH
  • VANGUARD CAPITAL MANAGEMENT LLC 351,910 SH
  • BOOTHBAY FUND MANAGEMENT, LLC 280,734 SH

Trades by members of Congress

See all insider transactions

Latest quarter

Revenue

6.91 million USD

2026 Q3 · USD

Exact inputs and evidence

Operating margin

-175.98%

2026 Q3 · %

Exact inputs and evidence
  • Operating Income: -12167000 USD Source
  • Revenue: 6914000 USD Source

Operating cash flow

-9.1 million USD

2026 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -27500000 USD Source
  • Operating Cash Flow: -18400000 USD Source
Cash and cash equivalents
14.4 million USD Source
Exact value

14400000 USD

Long-term debt including current maturities
0 USD
Exact inputs and evidence

0 USD

  • Long-term debt including current maturities: 0 USD Source
Shares outstanding
17.2 million shares Source
Exact value

17178786 shares

Reported share-count change

81.02% · 7.69 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 9490035 shares · 2025-09-30· Source
  • 17178786 shares · 2026-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

22.9 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Revenue: 35577000 USD · 2025-01-01 – 2025-12-31 Source
  • Revenue: 30485000 USD · 2025-01-01 – 2025-09-30 Source
  • Revenue: 5023000 USD · 2026-01-01 – 2026-03-31 Source
  • Revenue: 5862000 USD · 2026-04-01 – 2026-06-30 Source
  • Revenue: 6914000 USD · 2026-07-01 – 2026-09-30 Source

Net income

-43.3 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Net income: -17886000 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: -9812000 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: -9682000 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: -13153000 USD · 2026-04-01 – 2026-06-30 Source
  • Net income: -12407000 USD · 2026-07-01 – 2026-09-30 Source

Operating cash flow

-32.1 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Operating cash flow: -17600000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -13036000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -9200000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -18400000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -9200000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -27500000 USD · 2026-01-01 – 2026-09-30 Source
  • Operating cash flow: -18400000 USD · 2026-01-01 – 2026-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.

Latest filing recorded: 2026-11-13.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 5 of 11 periods available· newest 2025-12-31
  • Operating income: 9 of 11 periods available· newest 2025-12-31
  • Net income: 9 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 9 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 8 of 11 periods available· newest 2025-12-31
  • Total assets: 5 of 11 periods available· newest 2025-12-31
  • Total liabilities: 5 of 11 periods available· newest 2025-12-31
  • Current assets: 5 of 11 periods available· newest 2025-12-31
  • Current liabilities: 5 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 5 of 11 periods available· newest 2025-12-31
  • Long-term debt including current maturities: 4 of 11 periods available· newest 2025-12-31
  • Shares outstanding: 5 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +370.2%

    Prior period

    USD 7.57 million

    –

    Current period

    USD 35.58 million

    –

    Exact inputs and evidence

    35577000 − 7566000 = 28011000 USD

    7566000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    35577000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +USD 58.69 million

    Prior period

    −USD 76.58 million

    –

    Current period

    −USD 17.89 million

    –

    Exact inputs and evidence

    -17886000 − -76579000 = 58693000 USD

    -76579000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -17886000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 43.33 million

    Prior period

    −USD 60.93 million

    –

    Current period

    −USD 17.6 million

    –

    Exact inputs and evidence

    -17600000 − -60927000 = 43327000 USD

    -60927000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -17600000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -100%

    Prior period

    USD 27,000

    –

    Current period

    USD 0

    –

    Exact inputs and evidence

    0 − 27000 = -27000 USD

    27000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    0 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue USD 35.58 million 100% of revenue
  • Operating costs Derived USD 47.76 million 134% of revenue
  • Operating income −USD 12.19 million −34% of revenue
  • Tax, interest and other Derived USD 5.7 million 16% of revenue
  • Net income −USD 17.89 million −50% of revenue

Cash

  • Operating cash flow −USD 17.6 million −49% of revenue
  • Capital expenditure USD 0 0% of revenue
  • Free cash flow Derived −USD 17.6 million −49% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2021 Operating loss: operating costs were 358% of revenue.
  • 2022 Operating loss: operating costs were 336% of revenue.
  • 2023 Operating loss: operating costs were 1,383% of revenue.
  • 2024 Operating loss: operating costs were 971% of revenue.
  • 2025 Operating loss: operating costs were 134% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2021 2021-01-01 – 2021-12-3112000000 42908000 Derived -30908000 4172000 Derived -35080000 -28465000 Derived
Source
2022 2022-01-01 – 2022-12-319032000 30328000 Derived -21296000 3191000 Derived -24487000 -18952000 Derived
Source
2023 2023-01-01 – 2023-12-315124000 70883000 Derived -65759000 1236000 Derived -66995000 -38939000 Derived
Source
2024 2024-01-01 – 2024-12-317566000 73485000 Derived -65919000 10660000 Derived -76579000 -60954000 Derived
Source
2025 2025-01-01 – 2025-12-3135577000 47762000 Derived -12185000 5701000 Derived -17886000 -17600000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 35.6M 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.38.4M28.8M19.2M9.6M0.020212022202320242025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2021Revenue12000000
2022Revenue9032000
2023Revenue5124000
2024Revenue7566000
2025Revenue35577000

Revenue growth

Change in revenue from the same financial period one year earlier.

370.2% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.403%283%163%44%-76%20212022202320242025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2021Year over yearNo prior comparable period
2022Year over year-24.7%
2023Year over year-43.3%
2024Year over year47.7%
2025Year over year370.2%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -34.2% 2025
Net margin -50.3% 2025
Free cash flow margin -49.5% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.105%-275%-654%-1,033%-1,412%20212022202320242025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2021Operating margin-257.6%
2022Operating margin-235.8%
2023Operating margin-1,283.4%
2024Operating margin-871.3%
2025Operating margin-34.2%
2021Net margin-292.3%
2022Net margin-271.1%
2023Net margin-1,307.5%
2024Net margin-1,012.1%
2025Net margin-50.3%
2021Free cash flow margin-237.2%
2022Free cash flow margin-209.8%
2023Free cash flow margin-759.9%
2024Free cash flow margin-805.6%
2025Free cash flow margin-49.5%

Operating cash flow

Cash generated by the company’s normal business operations.

USD -17.6M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.4.9M-12.8M-30.5M-48.1M-65.8M20212022202320242025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2021Operating cash flow-27582000
2022Operating cash flow-18650000
2023Operating cash flow-38577000
2024Operating cash flow-60927000
2025Operating cash flow-17600000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -17.6M 2025
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.4.9M-12.8M-30.5M-48.2M-65.8M20212022202320242025
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2021Free cash flow-28465000
2022Free cash flow-18952000
2023Free cash flow-38939000
2024Free cash flow-60954000
2025Free cash flow-17600000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

47.5% 2025
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.128%96%64%32%0%20212022202320242025
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2021Liabilities / assets59.3%
2022Liabilities / assets10.5%
2023Liabilities / assets75.8%
2024Liabilities / assets118.2%
2025Liabilities / assets47.5%

Current assets to current liabilities

Current assets divided by current liabilities.

2.59× 2025
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.12.21×9.16×6.11×3.05×0.00×20212022202320242025
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2021Current assets / current liabilities1.61×
2022Current assets / current liabilities11.31×
2023Current assets / current liabilities4.55×
2024Current assets / current liabilities1.76×
2025Current assets / current liabilities2.59×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2017 2017-01-01 – 2017-12-31
−USD 4.46 million
Exact value

Exact value: -4459000 USD

2017-01-01 – 2017-12-31: -4459000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 4.58 million
Exact value

Exact value: -4583000 USD

2017-01-01 – 2017-12-31: -4583000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2018 2018-01-01 – 2018-12-31
−USD 20.65 million
Exact value

Exact value: -20648000 USD

2018-01-01 – 2018-12-31: -20648000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 17.87 million
Exact value

Exact value: -17874000 USD

2018-01-01 – 2018-12-31: -17874000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 774,000
Exact value

Exact value: 774000 USD

2018-01-01 – 2018-12-31: 774000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 18.65 million
Calculation and evidence

-17874000 − 774000 USD

Exact free cash flow: -18648000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2019 2019-01-01 – 2019-12-31
−USD 28.21 million
Exact value

Exact value: -28207000 USD

2019-01-01 – 2019-12-31: -28207000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 27.41 million
Exact value

Exact value: -27408000 USD

2019-01-01 – 2019-12-31: -27408000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 682,000
Exact value

Exact value: 682000 USD

2019-01-01 – 2019-12-31: 682000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 28.09 million
Calculation and evidence

-27408000 − 682000 USD

Exact free cash flow: -28090000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2020-01-01 – 2020-12-31
−USD 42.69 million
Exact value

Exact value: -42694000 USD

2020-01-01 – 2020-12-31: -42694000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 30.21 million
Exact value

Exact value: -30207000 USD

2020-01-01 – 2020-12-31: -30207000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.47 million
Exact value

Exact value: 1470000 USD

2020-01-01 – 2020-12-31: 1470000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 31.68 million
Calculation and evidence

-30207000 − 1470000 USD

Exact free cash flow: -31677000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 35.08 million
Exact value

Exact value: -35080000 USD

2021-01-01 – 2021-12-31: -35080000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 27.58 million
Exact value

Exact value: -27582000 USD

2021-01-01 – 2021-12-31: -27582000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 883,000
Exact value

Exact value: 883000 USD

2021-01-01 – 2021-12-31: 883000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 28.47 million
Calculation and evidence

-27582000 − 883000 USD

Exact free cash flow: -28465000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 24.49 million
Exact value

Exact value: -24487000 USD

2022-01-01 – 2022-12-31: -24487000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 18.65 million
Exact value

Exact value: -18650000 USD

2022-01-01 – 2022-12-31: -18650000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 302,000
Exact value

Exact value: 302000 USD

2022-01-01 – 2022-12-31: 302000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 18.95 million
Calculation and evidence

-18650000 − 302000 USD

Exact free cash flow: -18952000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 67 million
Exact value

Exact value: -66995000 USD

2023-01-01 – 2023-12-31: -66995000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 38.58 million
Exact value

Exact value: -38577000 USD

2023-01-01 – 2023-12-31: -38577000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 362,000
Exact value

Exact value: 362000 USD

2023-01-01 – 2023-12-31: 362000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 38.94 million
Calculation and evidence

-38577000 − 362000 USD

Exact free cash flow: -38939000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−USD 76.58 million
Exact value

Exact value: -76579000 USD

2024-01-01 – 2024-12-31: -76579000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 60.93 million
Exact value

Exact value: -60927000 USD

2024-01-01 – 2024-12-31: -60927000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 27,000
Exact value

Exact value: 27000 USD

2024-01-01 – 2024-12-31: 27000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 60.95 million
Calculation and evidence

-60927000 − 27000 USD

Exact free cash flow: -60954000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−USD 17.89 million
Exact value

Exact value: -17886000 USD

2025-01-01 – 2025-12-31: -17886000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 17.6 million
Exact value

Exact value: -17600000 USD

2025-01-01 – 2025-12-31: -17600000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 0
Exact value

Exact value: 0 USD

2025-01-01 – 2025-12-31: 0 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 17.6 million
Calculation and evidence

-17600000 − 0 USD

Exact free cash flow: -17600000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

63 filings · 2,382 latest values · 2,382 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001660334, 1660334, VRCA, edgar:1660334

Also known as Verrica Pharmaceuticals Inc.